Game-changing companies

Share this article:
Game-changing companies
Game-changing companies

Addison Whitney

To download a PDF of this profile, click here

Company Profile

Addison Whitney is a global branding firm with a passion for building strong brands. We specialize in verbal and visual branding, brand strategy and research.

Addison Whitney Health is a specialized division of ­Addison Whitney and is a global leader in pharmaceutical and healthcare brand development. We are part of ­inVentiv Health, a large network of clinical, commercial and consulting companies. Through this network, we are able to provide best-in-class services that deliver extraordinary outcomes to pharmaceutical, life sciences and biotech clients.

Addison Whitney Health's collaborative approach ­merges our industry expertise with your business strategy to develop engaging brands for every audience. This approach extends to our relationships with the FDA, EMA, Health Canada and other regulatory authorities—assuring your brand will gain approval and exist successfully in a clinical and commercial world. We deliver healthcare and pharmaceutical brands that integrate creativity, business strategy, trademark viability and regulatory compliances.

Services and Offerings

Verbal Branding
• Brand Name Development (Corporate/Product)
• REMS and Program Branding
• INN/USAN (Generic Name) Development
• Clinical Trial Naming
• Global Trademark Prescreening
• Global Linguistic Evaluation

Visual Branding
• Corporate, Product and Clinical Trial Logo Design
• Packaging Artwork
• Marketing Collateral and Tradeshow Materials
• Standards Program Development

Brand Strategy
• Brand Assessment
• Scientific Branding
• Brand Positioning and Messaging
• Brand Architecture
• Portfolio Nomenclature

Research & Analysis
• Brand Discovery/Positioning ­Research
• Name Validation Research (Regulatory & Marketing)
• Logo Validation Research (Regulatory & Marketing)
• Regulatory Name Submission Documents and ­Consulting

What will be the game-changing trend over the next five years?

In the next five years, the growing trend with biotech and pharmaceutical companies will continue to focus on bringing biosimilars to market.

With much debate on how non-proprietary drug nomenclature for biosimilars will be adopted, there will be even more focus on how manufacturers will brand their biosimilars. There's never been a more exciting time to be a branding firm—to help shape and differentiate these new brands as they compete for market share. The opportunity to create an impactful brand at more aggressive pricing to compete with current therapies will shape healthcare for the next generation.

Address 11525 N. Community House Rd., Suite 400, Charlotte, NC 28277 Phone 888.997.4155 Website New Business Contact Brannon Cashion, Global President, 704.697.4022, Year Founded 1991 Employees 50 Holding Company inVentiv Health Office Locations Charlotte (headquarters), New York, Seattle, London, Munich, Tokyo

Page 2 of 11
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Reimagining healthcare? We want to hear about it.
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters


More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric